Literature DB >> 33675653

First trimester mechanisms of gestational sac placental and foetal teratogenicity: a framework for birth cohort studies.

Jennifer J Adibi1,2, Alexander J Layden1,2, Rahel L Birru1, Alexandra Miragaia1, Xiaoshuang Xun1, Megan C Smith3, Qing Yin4, Marisa E Millenson5, Thomas G O'Connor6,7,8, Emily S Barrett9, Nathaniel W Snyder10, Shyamal Peddada4, Rod T Mitchell11.   

Abstract

BACKGROUND: The function of the gestational sac (GS) and the placenta in the closely related processes of embryogenesis and teratogenicity in the first trimester has been minimally described. The prevailing assumption is that direct teratogenic effects are mediated by the critical extraembryonic organ, the placenta, which either blocks or transfers exposures to the foetus. Placental transfer is a dominant mechanism, but there are other paradigms by which the placenta can mediate teratogenic effects. Knowledge of these paradigms and first trimester human developmental biology can be useful to the epidemiologist in the conduct of biomarker-based studies of both maternal and child health. OBJECTIVE AND RATIONALE: Our aim is to provide a causal framework for modelling the teratogenic effects of first trimester exposures on child health outcomes mediated by the GS and placenta using biomarker data collected in the first trimester. We initially present first trimester human developmental biology for the sake of informing and strengthening epidemiologic approaches. We then propose analytic approaches of modelling placental mechanisms by way of causal diagrams using classical non-embryolethal teratogens (diethylstilboestrol [DES], folic acid deficiency and cytomegalovirus [CMV]) as illustrative examples. We extend this framework to two chronic exposures of particular current interest, phthalates and maternal adiposity. SEARCH
METHODS: Information on teratogens was identified by a non-systematic, narrative review. For each teratogen, we included papers that answered the five following questions: (i) why were these exposures declared teratogens? (ii) is there a consensus on biologic mechanism? (iii) is there reported evidence of a placental mechanism? (iv) can we construct a theoretical model of a placental mechanism? and (v) can this knowledge inform future work on measurement and modelling of placental-foetal teratogenesis? We prioritized literature specific to human development, the organogenesis window in the first trimester and non-embryolethal mechanisms. OUTCOMES: As a result of our review of the literature on five exposures considered harmful in the first trimester, we developed four analytic strategies to address first trimester placental mechanisms in birth cohort studies: placental transfer and direct effects on the foetus (DES and maternal adiposity), indirect effects through targeted placental molecular pathways (DES and phthalates), pre-placental effects through disruptions in embryonic and extraembryonic tissue layer differentiation (folic acid deficiency), and multi-step mechanisms that involve maternal, placental and foetal immune function and inflammation (DES and CMV). WIDER IMPLICATIONS: The significance of this review is to offer a causal approach to classify the large number of potentially harmful exposures in pregnancy when the exposure occurs in the first trimester. Our review will facilitate future research by advancing knowledge of the first trimester mechanisms necessary for researchers to effectively associate environmental exposures with child health outcomes.
© The Author(s) 2021. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  biomarkers; cytomegalovirus (CMV); diethylstilboestrol (DES); epidemiology; first trimester; folic acid; gestational sac; phthalates; placenta; teratogen

Mesh:

Year:  2021        PMID: 33675653      PMCID: PMC8222765          DOI: 10.1093/humupd/dmaa063

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  211 in total

Review 1.  Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution.

Authors:  Eric Jauniaux; Lucilla Poston; Graham J Burton
Journal:  Hum Reprod Update       Date:  2006-05-08       Impact factor: 15.610

2.  Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes.

Authors:  Shi Wu Wen; Jia Zhou; Qiuying Yang; William Fraser; Olufemi Olatunbosun; Mark Walker
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

Review 3.  Immunology of the maternal-fetal interface.

Authors:  Adrian Erlebacher
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Effects of in utero and lactational exposure to phthalates on reproductive development and glycemic homeostasis in rats.

Authors:  Amanda Caroline Venturelli; Katlyn Barp Meyer; Stefani Valéria Fischer; Diogo Henrique Kita; Rafaela Adams Philipsen; Rosana Nogueira Morais; Anderson Joel Martino Andrade
Journal:  Toxicology       Date:  2019-03-30       Impact factor: 4.221

5.  Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid.

Authors:  Gillian M Scott; Sharon S W Chow; Maria E Craig; Chi N I Pang; Beverley Hall; Marc R Wilkins; Cheryl A Jones; Andrew R Lloyd; William D Rawlinson
Journal:  J Infect Dis       Date:  2012-03-01       Impact factor: 5.226

Review 6.  First Trimester Detection of Placental Disease: Challenges and Opportunities.

Authors:  Carolyn M Salafia; Diana M Thomas; Drucilla J Roberts; Jennifer K Straughen; Patrick M Catalano; Gabriela Perez-Avilan
Journal:  Am J Perinatol       Date:  2016-08-04       Impact factor: 1.862

Review 7.  Maternal hypertension and hypospadias in offspring: A systematic review and meta-analysis.

Authors:  Fatima R Sheriff; Adriana Lopez; Philip J Lupo; Abhishek Seth; Carolina Jorgez; A J Agopian
Journal:  Birth Defects Res       Date:  2018-11-08       Impact factor: 2.344

8.  Exposure to Di(2-ethylhexyl)phthalate in humans during pregnancy. A preliminary report.

Authors:  G Latini; C De Felice; G Presta; A Del Vecchio; I Paris; F Ruggieri; P Mazzeo
Journal:  Biol Neonate       Date:  2003

Review 9.  Metabolism of phthalates in humans.

Authors:  Hanne Frederiksen; Niels E Skakkebaek; Anna-Maria Andersson
Journal:  Mol Nutr Food Res       Date:  2007-07       Impact factor: 5.914

Review 10.  Effects of increased paternal age on sperm quality, reproductive outcome and associated epigenetic risks to offspring.

Authors:  Rakesh Sharma; Ashok Agarwal; Vikram K Rohra; Mourad Assidi; Muhammad Abu-Elmagd; Rola F Turki
Journal:  Reprod Biol Endocrinol       Date:  2015-04-19       Impact factor: 5.211

View more
  2 in total

1.  A study on the association of placental and maternal urinary phthalate metabolites.

Authors:  Hai-Wei Liang; Nathaniel Snyder; Jiebiao Wang; Xiaoshuang Xun; Qing Yin; Kaja LeWinn; Kecia N Carroll; Nicole R Bush; Kurunthachalam Kannan; Emily S Barrett; Rod T Mitchell; Fran Tylavsky; Jennifer J Adibi
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-09-16       Impact factor: 6.371

2.  Phthalate Exposures and Placental Health in Animal Models and Humans: A Systematic Review.

Authors:  Talia N Seymore; Zorimar Rivera-Núñez; Phoebe A Stapleton; Jennifer J Adibi; Emily S Barrett
Journal:  Toxicol Sci       Date:  2022-07-28       Impact factor: 4.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.